Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The World Bank’s Development Economics Vice Presidency (DEC) provides scholarships to students and young researchers, contributing to the World Bank’s mission of forging new dynamic approaches to ...

QClaw 's international beta opened with a number that sounds like footnote material until you think about what it implies: 99 ...

The UAB Heersink SOM MSTP provides a truly integrated MD-PhD training program for aspiring physician scientists. During the first 2-years of the program, our students take both a selection of medical ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiff Oncology , Revolution Medicines and Legend Biotech with bullish sentiments ...

Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...

In the spring of 2020, the digital world served as our global lighthouse, providing orientation and connection when the ...

AI is making it easier to design chips and optimize software for different silicon. Some startups envision a revolution in ...